Clinical Chemistry Siemens Point of Care - Urinalysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 49: 1740-1751, 2003; 10.1373/49.10.1740
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhan, X.
Right arrow Articles by Desiderio, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhan, X.
Right arrow Articles by Desiderio, D. M.
Related Collections
Right arrow Oak Ridge Conference
Right arrow Cancer Diagnostics (since 2002)
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2003;49:1740-1751.)
© 2003 American Association for Clinical Chemistry, Inc.

Oak Ridge Conference

Heterogeneity Analysis of the Human Pituitary Proteome

Xianquan Zhan1 and Dominic M. Desiderio1,2,3,a

1 The Charles B. Stout Neuroscience Mass Spectrometry Laboratory and the Departments of
2 Neurology and
3 Molecular Sciences, The University of Tennessee Health Science Center, Memphis, TN 38163.

aAddress correspondence to this author at: The University of Tennessee Health Science Center, 847 Monroe Ave., Room 117, Memphis, TN 38163. Fax 901-448-7842; e-mail ddesiderio{at}utmem.edu.


Abstract

Background: A human proteome is relatively dynamic compared with its corresponding genome. Our aim was to study the heterogeneity of a human pituitary proteome as a function of gender, age, and race.

Methods: Pituitary control tissues (n = 8) were used to extract proteins; each control tissue was analyzed (n = 3–5) with two-dimensional gel electrophoresis (2DGE) and PDQuest software. We obtained 30 high-resolution 2DGE gels and conducted a comparative analysis as a function of gender, age, and race. Matrix-assisted laser desorption/ionization-time of flight mass spectrometry and liquid chromatography-electrospray ionization-quadrupole-ion trap tandem mass spectrometry were used to characterize the protein in each differential spot.

Results: We detected ~1000 protein spots in each 2DGE map, and 51 differential spots (7 differing with gender, 17 with age, 15 with race, and 12 with the coeffect of age and race). Among those 51, we characterized 28 proteins [5 differing with gender, 8 with age, 6 with race, 8 with the coeffect of age and race, and 1 (somatotropin chain 1) with all of these]. Somatotropin was related to gender, age, and race, and prolactin was higher in females than males. The differentially expressed proteins that were related to age were mainly those proteins associated with cell growth, proliferation, differentiation, apoptosis, and death; those proteins showed no difference with gender and race. Age and race affected some proteins associated with hormone regulation (e.g., follistatin, thyroid hormone receptor ß-2, adenylate cyclase-inhibiting G{alpha} protein).

Conclusions: A heterogeneity exists in the human pituitary proteome as a function of gender, age, and race. These findings will serve as a basis for our comparative proteomics studies of human pituitary adenomas.




The following articles in journals at HighWire Press have cited this article:


Home page
 Mol. Cell. ProteomicsHome page
W.-J. Qian, J. M. Jacobs, T. Liu, D. G. Camp II, and R. D. Smith
Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1727 - 1744.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. S. Moreno, C.-O. Evans, X. Zhan, M. Okor, D. M. Desiderio, and N. M. Oyesiku
Novel Molecular Signaling and Classification of Human Clinically Nonfunctional Pituitary Adenomas Identified by Gene Expression Profiling and Proteomic Analyses
Cancer Res., November 15, 2005; 65(22): 10214 - 10222.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Shivji, S. Burger, C. A. Moncada, A. B. Clarkson Jr., and S. Merali
Effect of Nicotine on Lung S-Adenosylmethionine and Development of Pneumocystis Pneumonia
J. Biol. Chem., April 15, 2005; 280(15): 15219 - 15228.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
W.R. MacLellan, P. Ping, and T. Vondriska
Heart disease leaves its mark: Proteomics-based biosignatures in acute coronary syndromes
J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1584 - 1586.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.